Optimizing Outcomes When Treating Glabellar Lines

Aesthet Surg J. 2023 Jun 14;43(7):786-788. doi: 10.1093/asj/sjad087.
No abstract available

MeSH terms

  • Botulinum Toxins, Type A*
  • Double-Blind Method
  • Forehead / surgery
  • Humans
  • Neuromuscular Agents*
  • Patient Satisfaction
  • Skin Aging*
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents